Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Zwibel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the Neurological Sciences|January 29, 2010
Health and quality of life in patients with relapsing multiple sclerosis: making the intangible tangibleHoward Zwibel
Neurology|February 28, 2002
The cost of delaying treatment in multiple sclerosis: what is lost is not regainedHoward Zwibel
Neurology|December 30, 2004
Mitoxantrone for multiple sclerosis in clinical practiceSyed A Rizvi, Howard Zwibel, Edward J Fox
Journal of Neurology|October 6, 2010
A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosisHoward Zwibel, Gabriel Pardo, Shelly Smith, et al.
BMC Neurology|March 15, 2014
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomesPatricia K Coyle, Bruce A Cohen, Thomas Leist, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the Neurological Sciences|January 29, 2010
Health and quality of life in patients with relapsing multiple sclerosis: making the intangible tangibleHoward Zwibel
Neurology|February 28, 2002
The cost of delaying treatment in multiple sclerosis: what is lost is not regainedHoward Zwibel
Neurology|December 30, 2004
Mitoxantrone for multiple sclerosis in clinical practiceSyed A Rizvi, Howard Zwibel, Edward J Fox
Journal of Neurology|October 6, 2010
A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosisHoward Zwibel, Gabriel Pardo, Shelly Smith, et al.
BMC Neurology|March 15, 2014
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomesPatricia K Coyle, Bruce A Cohen, Thomas Leist, et al.
Pageof 1